UCB's Global Corporate Website

UCB0022

Disease area studied Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available)
Parkinson's Disease A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease (ATLANTIS) Phase 2 PD0060
Ongoing
NCT06055985
Parkinson's Disease A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's Disease Phase 1 UP0091
Ongoing
NCT04867642